Volgen
Karin van Garderen
Karin van Garderen
Postdoctoral researcher, Erasmus MC
Geverifieerd e-mailadres voor erasmusmc.nl
Titel
Geciteerd door
Geciteerd door
Jaar
The effect of preprocessing on convolutional neural networks for medical image segmentation
KB De Raad, KA van Garderen, M Smits, SR van der Voort, F Incekara, ...
2021 IEEE 18th International Symposium on Biomedical Imaging (ISBI), 655-658, 2021
242021
Towards continuous learning for glioma segmentation with elastic weight consolidation
K van Garderen, S van der Voort, F Incekara, M Smits, S Klein
arXiv preprint arXiv:1909.11479, 2019
202019
Multi-modal segmentation with missing MR sequences using pre-trained fusion networks
K van Garderen, M Smits, S Klein
Domain Adaptation and Representation Transfer and Medical Image Learning …, 2019
122019
Effect of applying leakage correction on rcbv measurement derived from dsc-mri in enhancing and nonenhancing glioma
F Arzanforoosh, PL Croal, KA van Garderen, M Smits, MA Chappell, ...
Frontiers in Oncology 11, 648528, 2021
92021
EASE: clinical implementation of automated tumor segmentation and volume quantification for adult low-grade glioma
KA van Garderen, SR van der Voort, A Versteeg, M Koek, A Gutierrez, ...
Frontiers in Medicine 8, 738425, 2021
52021
Association of pre-radiotherapy tumour burden and overall survival in newly diagnosed glioblastoma adjusted for MGMT promoter methylation status
A Alafandi, KA van Garderen, S Klein, SR van der Voort, D Rizopoulos, ...
European Journal of Cancer 188, 122-130, 2023
22023
Pre-contrast MAGiC in treated gliomas: a pilot study of quantitative MRI
L Nunez-Gonzalez, KA van Garderen, M Smits, J Jaspers, AM Romero, ...
Scientific Reports 12 (1), 21820, 2022
22022
OS07. 8. A Prognosis in IDH-mutant glioma: the role of extent-of-resection, age and tumor grade
T Van der Vaart, MMJ Wijnenga, KA van Garderen, H Dubbink, PJ French, ...
Neuro-oncology 24 (Suppl 2), ii17, 2022
22022
Active learning for overlay prediction in semi-conductor manufacturing
K van Garderen
22018
Evaluating glioma growth predictions as a forward ranking problem
KA van Garderen, SR van der Voort, MMJ Wijnenga, F Incekara, ...
International MICCAI Brainlesion Workshop, 100-111, 2021
12021
Treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma undergoing chemoradiation with or without cilengitide
CM Flies, M Friedrich, P Lohmann, KA van Garderen, M Smits, JC Tonn, ...
Neuro-oncology, noad247, 2024
2024
OS06. 6. A FLAIR-SIGNAL INTENSITY CHANGE AS A PREDICTOR OF PROGRESSIVE GLIOBLASTOMA IN THE EORTC CENTRIC AND CORE STUDIES
CM Flies, M Friedrich, P Lohmann, K van Garderen, M Smits, JC Tonn, ...
Neuro-Oncology 25 (Supplement_2), ii17-ii18, 2023
2023
Evaluating the predictive value of glioma growth models for low-grade glioma after tumor resection
KA van Garderen, SR van der Voort, MMJ Wijnenga, F Incekara, ...
IEEE Transactions on Medical Imaging, 2023
2023
Deep learning-based group-wise registration for longitudinal MRI analysis in glioma
CC Hammecher, K van Garderen, M Smits, P Wesseling, B Westerman, ...
arXiv preprint arXiv:2306.10611, 2023
2023
Deep learning-based group-wise registration for longitudinal MRI analysis in glioma
C Chinea Hammecher, K van Garderen, M Smits, P Wesseling, ...
arXiv e-prints, arXiv: 2306.10611, 2023
2023
Neuro-Oncology Advances
KA van Garderen, WR Vallentgoed, A Lavrova, JM Niers, WWJ de Leng, ...
2023
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort
KA van Garderen, WR Vallentgoed, A Lavrova, JM Niers, WWJ de Leng, ...
Neuro-oncology advances 5 (1), vdad149, 2023
2023
P07. 11. A Impact of awake craniotomy on extent-of-resection and performance in glioma: a retrospective, propensity-score matched cohort study
SJP Schnitzler, T van der Vaart, K van Garderen, MJ van den Bent, ...
Neuro-Oncology 24 (Suppl 2), ii42, 2022
2022
P17. 19. B Incidence of treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma treated with cilengitide (EORTC 26071-CENTRIC study …
CM Flies, M Friedrich, P Lohmann, K van Garderen, M Smits, JC Tonn, ...
Neuro-Oncology 24 (Supplement_2), ii93-ii93, 2022
2022
OS08. 1. A Integrative molecular analysis of matched primary and recurrent IDH-mutant astrocytoma; an update from the GLASS-NL consortium
WR Vallentgoed, Y Hoogstrate, E van Dijk, K van Garderen, A Niers, ...
Neuro-Oncology 24 (Supplement_2), ii18-ii18, 2022
2022
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20